Estonja - Estonjan - Ravimiamet

orifarm healthcare a/s - metadoon - suukaudne lahus - 1mg 1ml 1000ml 1tk

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

eurogenerics holdings b.v. - teriparatiid - osteoporoos - kaltsiumi homöostaas - qutavina is indicated in adults. osteoporoosi ravi postmenopausis naistel ja meestel, kellel on suurem luumurdude risk. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. ravi osteoporoosi seostatakse pidevat süsteemset glükokortikoidi ravi naiste ja meeste suurenenud risk luumurdude.

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

novo nordisk a/s - somapacitan - kasv - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic kasvajad, kastreerimine-vastupidavad - antineoplastilised ained - treatment of adult patients with prostate cancer.

Estonja - Estonjan - Ravimiamet

cp-pharma handelsgesellschaft mbh - trilostaan - närimistablett - 30mg 30tk; 30mg 100tk

Estonja - Estonjan - Ravimiamet

cp-pharma handelsgesellschaft mbh - trilostaan - närimistablett - 10mg 30tk; 10mg 100tk

Estonja - Estonjan - Ravimiamet

cp-pharma handelsgesellschaft mbh - trilostaan - närimistablett - 60mg 100tk

Estonja - Estonjan - Ravimiamet

cp-pharma handelsgesellschaft mbh - trilostaan - närimistablett - 120mg 30tk

Estonja - Estonjan - Ravimiamet

cp-pharma handelsgesellschaft mbh - trilostaan - närimistablett - 150mg 100tk; 150mg 30tk